CGRP as the target of new migraine therapies — successful translation from bench to clinic

  title={CGRP as the target of new migraine therapies — successful translation from bench to clinic},
  author={L. Edvinsson and K. Haanes and K. Warfvinge and D. Krause},
  journal={Nature Reviews Neurology},
  • L. Edvinsson, K. Haanes, +1 author D. Krause
  • Published 2018
  • Medicine
  • Nature Reviews Neurology
  • Treatment of migraine is on the cusp of a new era with the development of drugs that target the trigeminal sensory neuropeptide calcitonin gene-related peptide (CGRP) or its receptor. Several of these drugs are expected to receive approval for use in migraine headache in 2018 and 2019. CGRP-related therapies offer considerable improvements over existing drugs as they are the first to be designed specifically to act on the trigeminal pain system, they are more specific and they seem to have few… CONTINUE READING
    218 Citations

    Paper Mentions

    Observational Clinical Trial
    Migraine is the 2nd most disabling neurological disease. It affects 14.7% of the population (children and adults) of whom 80% are female. In the EU, the total annual cost of migraine is… Expand
    CGRP-based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?
    • A. Russo
    • Medicine
    • ACS pharmacology & translational science
    • 2019
    • 9
    Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
    • 8
    Monoclonal antibodies for the prevention of migraine
    • 11
    • Highly Influenced
    Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models
    • 11


    CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.
    • L. Edvinsson
    • Chemistry, Medicine
    • British journal of clinical pharmacology
    • 2015
    • 118
    Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists
    • L. Edvinsson
    • Medicine
    • Expert opinion on therapeutic targets
    • 2007
    • 19
    Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
    • 78
    CGRP-receptor antagonism in migraine treatment.
    • 37
    Therapeutic antibodies against CGRP or its receptor.
    • 73
    Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine.
    • I. M. Bell
    • Chemistry, Medicine
    • Journal of medicinal chemistry
    • 2014
    • 43